Elimination of African onchocerciasis: Modeling the impact of increasing the frequency of ivermectin mass treatment

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Coffeng, Luc E ^a   Stolk, Wilma A ^a   Hoerauf, Achim ^b   Habbema, Dik ^a   Bakker, Roel ^a   Hopkins, Adrian D ^c   De Vlas, Sake J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c Mectizan Donation Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN;

ARTICLE; COMPUTER SIMULATION; COST BENEFIT ANALYSIS; DISEASE ELIMINATION; DRUG EFFICACY; DRUG RESISTANCE; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; MASS TREATMENT; MATHEMATICAL MODEL; MIGRATION; ONCHOCERCIASIS; PARASITE TRANSMISSION; TREATMENT DURATION; AFRICA; ANIMAL; BIOLOGICAL MODEL; DISEASE ERADICATION; HUMAN; ONCHOCERCA VOLVULUS; PARASITOLOGY; PROBABILITY; SKIN; SUPPLY AND DISTRIBUTION; TIME; TREATMENT OUTCOME;

AFRICA; ANIMALS; COMPUTER SIMULATION; DISEASE ERADICATION; HUMANS; IVERMECTIN; MODELS, BIOLOGICAL; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PROBABILITY; SKIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84920155954     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115886     Document Type: Article

References (49)

1. Amazigo U (2008) The African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol 102 Suppl: 19-22.
2. Diawara L, Traoré MO, Badji A, Bissan Y, Doumbia K, et al. (2009) Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis 3: e497.
3. Tekle AH, Elhassan E, Isiyaku S, Amazigo UV, Bush S, et al. (2012) Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control. Parasit Vectors 5: 28.
4. Traore MO, Sarr MD, Badji A, Bissan Y, Diawara L, et al. (2012) Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal. PLoS Negl Trop Dis 6: e1825.
5. African Programme for Onchocerciasis Control (2010) Conceptual and operational framework of onchocerciasis elimination with ivermectin treatment. Ouagadougou.
6. Cupp EW, Sauerbrey M, Richards F (2011) Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(H)) monotherapy. Acta Trop 120 Suppl: S100-S108.
7. Sauerbrey M (2008) The Onchocerciasis Elimination Program for the Americas (OEPA). Ann Trop Med Parasitol 102 Suppl: 25-29.
8. Stolk WA, ten Bosch QA, de Vlas SJ, Fischer PU, Weil GJ, et al. (2013) Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis. PLoS Negl Trop Dis 7: e1984.
9. Basáñez M-G, Churcher TS, Grillet M-E (2009) Onchocerca-Simulium interactions and the population and evolutionary biology of Onchocerca volvulus. Adv Parasitol 68: 263-313.
10. Coffeng LE, Stolk WA, Zouré HGM, Veerman JL, Agblewonu KB, et al. (2013) African Programme for Onchocerciasis Control 1995-2015: model-estimated health impact and cost. PLoS Negl Trop Dis 7: e2032.
11. Winnen M, Plaisier AP, Alley ES, Nagelkerke NJD, van Oortmarssen G, et al. (2002) Can ivermectin mass treatments eliminate onchocerciasis in Africa? Bull World Heal Organ 80: 384-391.
12. Plaisier AP, van Oortmarssen GJ, Habbema JD, Remme J, Alley ES (1990) ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. Comput Methods Programs Biomed 31: 43-56.
13. Habbema JDF, Oostmarssen GJ, Plaisier AP (1996) The ONCHOSIM model and its use in decision support for river blindness control. In: Isham V, Medley G. Models for infectious human diseases - their stucture and relation to data. Cambridge: Cambridge University Press. pp. 360-380.
14. Plaisier AP, Alley ES, Boatin BA, Van Oortmarssen GJ, Remme H, et al. (1995) Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa. J Infect Dis 172: 204-210.
15. Plaisier AP, Alley ES, van Oortmarssen GJ, Boatin BA, Habbema JD (1997) Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in west Africa. Bull World Heal Organ 75: 237-245.
16. Plaisier AP, van Oortmarssen GJ, Remme J, Alley ES, Habbema JD (1991) The risk and dynamics of onchocerciasis recrudescence after cessation of vector control. Bull World Heal Organ 69: 169-178.
17. Plaisier AP, van Oortmarssen GJ, Remme J, Habbema JD (1991) The reproductive lifespan of Onchocerca volvulus in West African savanna. Acta Trop 48: 271-284.
18. Churcher TS, Ferguson NM, Basáñez MG (2005) Density dependence and overdispersion in the transmission of helminth parasites. Parasitology 131: 121-132.
19. Alley ES, Plaisier AP, Boatin BA, Dadzie KY, Remme J, et al. (1994) The impact of five years of annual ivermectin treatment on skin microfilarial loads in the onchocerciasis focus of Asubende, Ghana. Trans R Soc Trop Med Hyg 88: 581-584.
20. Chavasse DC, Post RJ, Davies JB, Whitworth JA (1993) Absence of sperm from the seminal receptacle of female Onchocerca volvulus following multiple doses of ivermectin. Trop Med Parasitol 44: 155-158.
21. Kläger S, Whitworth JA, Post RJ, Chavasse DC, Downham MD (1993) How long do the effects of ivermectin on adult Onchocerca volvulus persist? Trop Med Parasitol 44: 305-310.
22. Cupp EW, Duke BO, Mackenzie CD, Guzmán JR, Vieira JC, et al. (2004) The effects of long-term community level treatment with ivermectin (Mectizan) on adult Onchocerca volvulus in Latin America. Am J Trop Med Hyg 71: 602-607.
23. Cupp EW, Cupp MS (2005) Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year. Am J Trop Med Hyg 73: 1159-1161.
24. Duke BO, Pacqué MC, Muñoz B, Greene BM, Taylor HR (1991) Viability of adult Onchocerca volvulus after six 2-weekly doses of ivermectin. Bull World Heal Organ 69: 163-168.
25. Duke BO, Zea-Flores G, Castro J, Cupp EW, Muñoz B (1990) Effects of multiple monthly doses of ivermectin on adult Onchocerca volvulus. Am J Trop Med Hyg 43: 657-664.
26. Duke BO, Zea-Flores G, Castro J, Cupp EW, Muñoz B (1991) Comparison of the effects of a single dose and of four six-monthly doses of ivermectin on adult Onchocerca volvulus. Am J Trop Med Hyg 45: 132-137.
27. Duke BO, Zea-Flores G, Castro J, Cupp EW, Muñoz B (1992) Effects of three-month doses of ivermectin on adult Onchocerca volvulus. Am J Trop Med Hyg 46: 189-194.
28. Duke BOL (2005) Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms. Parasitology 130: 447-453.
29. Gardon J, Boussinesq M, Kamgno J, Gardon-Wendel N, Demanga-Ngangue, et al. (2002) Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial. Lancet 360: 203-210.
30. Kläger SL, Whitworth JA, Downham MD (1996) Viability and fertility of adult Onchocerca volvulus after 6 years of treatment with ivermectin. Trop Med Int Heal 1: 581-589.
31. Basáñez M-G, Pion SDS, Boakes E, Filipe JAN, Churcher TS, et al. (2008) Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect Dis 8: 310-322.
32. Soumbey-Alley E, Basáñez M-G, Bissan Y, Boatin BA, Remme JHF, et al. (2004) Uptake of Onchocerca volvulus (Nematoda: Onchocercidae) by Simulium (Diptera: Simuliidae) is not strongly dependent on the density of skin microfilariae in the human host. J Med Entomol 41: 83-94.
33. Duerr HP, Raddatz G, Eichner M (2011) Control of onchocerciasis in Africa: threshold shifts, breakpoints and rules for elimination. Int J Parasitol 41: 581-589.
34. Bottomley C, Isham V, Collins RC, Basáñez M-G (2008) Rates of microfilarial production by Onchocerca volvulus are not cumulatively reduced by multiple ivermectin treatments. Parasitology 135: 1571-1581.
35. Pion SDS, Nana-Djeunga HC, Kamgno J, Tendongfor N, Wanji S, et al. (2013) Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon. PLoS Negl Trop Dis 7: e2084.
36. Turner HC, Churcher TS, Walker M, Osei-Atweneboana MY, Prichard RK, et al. (2013) Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis. PLoS Negl Trop Dis 7: e2169.
37. Awadzi K, Attah SK, Addy ET, Opoku NO, Quartey BT, et al. (2004) Thirty-month follow-up of suboptimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol 98: 359-370.
38. Osei-Atweneboana MY, Awadzi K, Attah SK, Boakye DA, Gyapong JO, et al. (2011) Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus. PLoS Negl Trop Dis 5: e998.
39. Osei-Atweneboana MY, Boakye DA, Awadzi K, Gyapong JO, Prichard RK (2012) Genotypic analysis of b-tubulin in Onchocerca volvulus from communities and individuals showing poor parasitological response to ivermectin treatment. Int J Parasitol Drugs Drug Resist 2: 20-28.
40. Nana-Djeunga HC, Bourguinat C, Pion SD, Bopda J, Kengne-Ouafo JA, et al. (2014) Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naïve and a frequently treated population from Cameroon. PLoS Negl Trop Dis 8: e2824.
41. Basáñez M-G, Remme JH, Alley ES, Bain O, Shelley AJ, et al. (1995) Density-dependent processes in the transmission of human onchocerciasis: relationship between the numbers of microfilariae ingested and successful larval development in the simuliid vector. Parasitology 110 (Pt 4): 409-427.
42. Duerr HP, Dietz K, Schulz-Key H, Bü ttner DW, Eichner M (2004) The relationships between the burden of adult parasites, host age and the microfilarial density in human onchocerciasis. Int J Parasitol 34: 463-473.
43. Coffeng LE, Pion SDS, O9Hanlon S, Cousens S, Abiose AO, et al. (2013) Onchocerciasis: the precontrol association between prevalence of palpable nodules and skin microfilariae. PLoS Negl Trop Dis 7: e2168.
44. African Programme for Onchocerciasis Control: meeting of National Onchocerciasis Task Forces, September 2013. (2013). Wkly Epidemiol Rec 88: 533-544.
45. Turner HC, Osei-Atweneboana MY, Walker M, Tettevi EJ, Churcher TS, et al. (2013) The Cost of Annual versus Biannual Community-Directed Treatment of Onchocerciasis with Ivermectin: Ghana as a Case Study. PLoS Negl Trop Dis 7: e2452.
46. Mwinzi PNM, Montgomery SP, Owaga CO, Mwanje M, Muok EM, et al. (2012) Integrated communitydirected intervention for schistosomiasis and soil transmitted helminths in western Kenya - a pilot study. Parasit Vectors 5: 182.
47. Dembé lé M, Bamani S, Dembé lé R, Traoré MO, Goita S, et al. (2012) Implementing preventive chemotherapy through an integrated National Neglected Tropical Disease Control Program in Mali. PLoS Negl Trop Dis 6: e1574.
48. Coulibaly Y, Cavalli A, van Dormael M, Polman K, Kegels G (2008) Programme activities: a major burden for district health systems? Trop Med Int Heal 13: 1430-1432.
49. World Health Organization (2012) Accelerating work to overcome the global impact of neglected tropical diseases - a roadmap for implementation.